BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38524631)

  • 1. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome.
    Gato S; García-Fernández V; Gil-Gómez A; Rojas Á; Montero-Vallejo R; Muñoz-Hernández R; Romero-Gómez M
    Eur Cardiol; 2024; 19():e03. PubMed ID: 38807856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and emerging treatments for metabolic dysfunction-associated steatohepatitis.
    Tincopa MA; Anstee QM; Loomba R
    Cell Metab; 2024 May; 36(5):912-926. PubMed ID: 38608696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis.
    Med Lett Drugs Ther; 2024 Apr; 66(1701):65-66. PubMed ID: 38691644
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.
    Chondrogianni ME; Kyrou I; Androutsakos T; Flessa CM; Menenakos E; Chatha KK; Aranan Y; Papavassiliou AG; Kassi E; Randeva HS
    Front Endocrinol (Lausanne); 2024; 15():1344376. PubMed ID: 38524631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease.
    Powell EE; Wong VW; Rinella M
    Lancet; 2021 Jun; 397(10290):2212-2224. PubMed ID: 33894145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease.
    Chrysavgis L; Papatheodoridi AM; Chatzigeorgiou A; Cholongitas E
    J Gastroenterol Hepatol; 2021 Apr; 36(4):893-909. PubMed ID: 33439540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.
    Muzica CM; Sfarti C; Trifan A; Zenovia S; Cuciureanu T; Nastasa R; Huiban L; Cojocariu C; Singeap AM; Girleanu I; Chiriac S; Stanciu C
    Can J Gastroenterol Hepatol; 2020; 2020():6638306. PubMed ID: 33425804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of TNF-α, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease.
    Wang TH; Li JB; Tian YG; Zheng JX; Li XD; Guo SZ
    J Orthop Surg Res; 2023 Dec; 18(1):915. PubMed ID: 38041076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
    Zachou M; Flevari P; Nasiri-Ansari N; Varytimiadis C; Kalaitzakis E; Kassi E; Androutsakos T
    Eur J Clin Pharmacol; 2024 Jan; 80(1):127-150. PubMed ID: 37938366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
    Jaroenlapnopparat A; Rittiphairoj T; Chaisidhivej N; Walker B; Charoenngam N
    Diabetes Metab Syndr; 2023 Aug; 17(8):102827. PubMed ID: 37451113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease Is Associated With Decreased Bone Mineral Density in Adults: A Systematic Review and Meta-Analysis.
    Su YH; Chien KL; Yang SH; Chia WT; Chen JH; Chen YC
    J Bone Miner Res; 2023 Aug; 38(8):1092-1103. PubMed ID: 37254266
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.